For comparison of mammary gland whole mounts with examination of 2 histologic sections of mammary gland, 56 Hras128 rats were intravenously injected with 50 mg/kg body weight of N -methyl-N -nitrosourea at 50 days of age and then sacrificed at days 5, 10, 15, 20, 25, and 56. Comparison of detection sensitivity between the whole mounts and histologic sections revealed no lesions apparent in whole mounts on day 10, although intraductal proliferation was clearly detected in histologic sections in 44% of treated rats. Proliferative lesions were first detected in whole mounts at a 44% incidence on day 15, while intraductal proliferations and atypical hyperplasias were apparent in the sections at 89% and 44% incidences, respectively. On day 20, atypical hyperplasias and small adenocarcinomas in histologic sections were found in almost all animals. In conclusion, examination of 2 histologic sections from mammary tissues was found to be practical for detection of small malignant lesions as early as 15 days after MNU injection, and suppressive effects of soy isoflavones were clearly evident within 20 days after carcinogen exposure. These results suggest that this model has practical utility for short-term screening of chemopreventive agents for mammary carcinogenesis.
INTRODUCTION
Induction of mammary carcinogenesis by administration of either N -methyl-N -nitrosourea (MNU) or 7,12dimethylbenz[a]anthracene (DMBA) to virgin female rats is widely used for experimental studies of mammary carcinogenesis (19, 22, 28, (32) (33) (34) . Transgenic techniques have been used to create many animal models of human disease, and transgenic mice harboring the human c-Ha-ras protooncogene (1, 37) , v-Ha-ras (29) , or pim-1 (27) as well as p53 knockout mice (10, 16) have been shown to be highly susceptible to tumor induction by certain carcinogens and therefore of possible use for rapid screening purposes (30) . Recently, transgenic mouse lines harboring human oncogenes such as c-myc and TGFα or both, were reported to exhibit marked sensitivity to environmental liver carcinogens (35) .
Despite frequent use in chemical carcinogenesis studies and also assays of carcinogenicity, only a few transgenic rat lines with high susceptibility to chemical carcinogenesis have been established (7, 12) . We have generated one line carrying the human c-Ha-ras proto-oncogene (Hras128) that demonstrates high susceptibility regarding chemical induction of mammary, urinary bladder, and esophageal tumors (2, 3, 15) . All of the females develop multiple mammary carcinomas within 8-12 weeks after administration of MNU or DMBA (2, 36) . The period required for palpable tumor development is generally 28 and 40 days after MNU or DMBA administration, respectively, when nontransgenic female Sprague-Dawley (SD) rats are treated at 50-60 days of age (20, 31, 33) .
Stepwise progression from intraductal proliferation through ductal carcinoma in situ to invasive carcinomas has been reported with both carcinogens (20, 21) . In terms of histogenesis, pathology, and sensitivity to hormones, the induced lesions closely resemble those in humans (21, 26) .
The age-adjusted death rates from breast cancer are from 2-to 8-folds less in Asian countries than in the United States and Western Europe. This appears related to the 20-50 times greater consumption of soybean products (14, 18) . In vivo and in vitro studies have indicated that genistein, one of the isoflavones in soybean, may be responsible for tumor suppressive effects (4, 5, 8, 24, 25) .
In the present study, the process of carcinogenesis in a transgenic rat model was analyzed, concentrating attention on early lesion development. The abdominal-inguinal mammary glands (AIMG) were utilized in most of the analyses to determine sensitivity and practicability of our system, although rat mammary tissue is in fact composed of 6 pairs of the glands located from the upper thoracic to inguinal regions. Using this transgenic rat model in combination with a simple histology-based approach, tumor suppressive effects of soy isoflavones could be detected within a period as short as 20 days. Vol. 31, No. 6, 2003 MAMMARY CARCINOGENESIS IN c-H-ras TRANSGENIC RATS 633
MATERIALS AND METHODS

Animals and Treatment
Hras128 and littermate nontransgenic female rats were bred under SPF conditions by CLEA Japan Co, Ltd, Tokyo. They were housed 3 per cage in an environmentally controlled animal facility maintained at 22 • C and 55% relative humidity with a 12-hour light-dark cycle, and fed a semipurified diet, soybean powder being replaced by corn, wheat, bran, and fish meat powders to minimize isoflavone contamination (Oriental Yeast Co Ltd, Tokyo, Japan). On day 50 after birth, they were injected intravenously with MNU (Sigma-Aldrich Japan, Tokyo), 50 mg/kg body weight, then euthanized by bleeding from the inferior vena cava under anesthesia at days 5, 10, 15, 20, 25, or 56 thereafter.
For the study of sensitivity for detection of early lesions (5-25 days after MNU), incidences of proliferative intraductal lesions (PIL) in whole mount preparations from the right abdominal-inguinal mammary glands (AIMG) and 2 histologic sections prepared from proximal and distal halves of the left AIMG of the same animals were compared. For -Method for preparation of whole mount preparations and tissue block paraffin sections from AIMG. Whole mounts were taken from the right AIMG and tissue blocks were from the left side. The tissue blocks were excised with fat pad then cut into 2 pieces, processed for paraffin embedding then sectioned in the proximal to distal axis. assessment of chemopreventive effects, animals were fed basal diet containing 0.25% (w/w) of soybean isoflavones (provided by Kikkoman Corporation, Japan) and were sacrificed on days 20 and 56 for the comparison of data on proliferative lesion development using whole mounts and histologic sections. The isoflavone mix cantained daidzein (38.32%), genistein (30.14%), glycitein (5.07%) (total, 73.53%), with some saponin, soybean pectin, and amino acids as other components. Tumor weight was measured by weighing excised grossly visible nodular lesions at necropsy. The experiments were conducted according to the "Guidelines for Animal Experiments in National Cancer Center" of the Committee for Ethics of Animal Experimentation of the National Cancer Center, Japan.
Whole Mount Mammary Gland Preparations
Whole mounts were carefully made by removing the mammary fat pad including the right side AIMG (Figure 1 ), then fixed in 10% buffered formalin for 12-18 hours after stretching on filter papers, rinsed in distilled water for 1 hour, TOXICOLOGIC PATHOLOGY immersed overnight in alum carmine, then rinsed again in distilled water. After the staining was completed, the whole mounts were dehydrated through a series of ethanols (70, 95, and 100%), diethyl ether, and cleared in benzene. Each whole mount was then placed in a clear heat seal pouch filled with cedar oil (Wako Pure Chemical, Osaka, Japan). PIL were viewed under a low-power stereoscopic microscope. Some PIL and mammary ducts on days 15 and 20 were subjected to histological analysis after direct excision under a stereoscope and routine processing for paraffin embedding.
Histological Examination
For the histological examination of the left side AIMG, mammary tissues were excised from the subcutaneous tissue with scissors along with the fat pads, then cut into 2 pieces, the proximal region including a lymph node and the distal region. After fixation in acetone, they were separately embedded in paraffin, and 4-µm thick sections for each block, a total of 2 sections along the longitudinal axis from the proximal to the distal regions, were prepared and stained with HE ( Figure 1 ). This simple method was utilized for histological examination of the mammary glands on days 5-25. On day 56, tumors were individually excised and subjected to histological examination. Lesions were classified based on the criteria described by Russo (22) and Singh (26) . Small epithelial proliferative lesions without invasion were classified as intraductal proliferations and atypical hyperplasias, the latter showing slight cellular and structural atypia. Cases with obvious invasion were diagnosed as adenocarcinomas. Atypical hyperplasias and adenocarcinomas were combined as early carcinomas when assessing effects of soy isoflavones on day 20 since differential diagnosis between atypical hyperplasias and small adenocarcinomas was often difficult and unnecessary for the purpose of the study. Lesion multiplicity was calculated by dividing the number of total lesions by the areas of sections and expressed as number per cm 2 . Acetone fixation is routinely used in our laboratory because of better conservation of antigenicity than with formalin as reported previously (6, 23) .
Statistics
The data for tumor incidences were analyzed by the Fisher's exact probability test. Differences in quantitative values for lesion multiplicity were assessed with Dunnett's t-test.
RESULTS
Since establishment of a short term, simple method for assessing mammary chemical carcinogenesis was our prime objective, AIMG only were subjected to preparation of whole mounts and histologic sections, unless otherwise specified. In whole mounts, no gross lesions were detected until day 10 (Figure 2A ). Typical PIL were firstly observed on day 15 in Hras128 rats ( Figure 2B ). At day 20 and thereafter, all the rats had such lesions, as shown in Figure 2C . Most PIL (dark irregular shaped masses) were found located proximal to terminal endbuds (TEBs) (arrows in Figures 2B and 2C ) considered as targets of chemical carcinogens in the mammary glands (20) . Histological analysis of whole mount preparations indicated that the PIL were intraductal proliferations ( Figure 3A ), atypical hyperplasias ( Figure 3B) , and adenocarcinomas ( Figures 3C and 3D ), clearly correlating with the histological appearance of lesions in tissue block preparations of the contralateral AIMG. Therefore, for the assessment of tumor incidence and multiplicity, 2 slices from each block taken from AIMG were subjected to time sequence histological analysis (Figure 1, right half) .
Although no lesions could be detected in whole mount preparations on day 10, intraductal proliferations were found in histologic sections. At day 15, both foci of intraductal proliferation and atypical hyperplasias were detected. On day 20, in addition to high incidences of intraductal proliferations and atypical hyperplasias, adenocarcinomas were observed. Incidences of PIL in whole mounts and lesions in the histologic sections reached 100% by day 25, and that Vol. 31, No. 6, 2003 MAMMARY CARCINOGENESIS IN c-H-ras TRANSGENIC RATS 635 of palpable adenocarcinomas in Hras128 rats did by day 56 ( Table 1) . Incidences of the tumors in right and left sides of entire mammary glands were the same on day 56.
Data for suppressive effects of soy isoflavones on mammary tumor incidence and multiplicity data between whole mounts and tissue block section of rats sacrificed on day 20 are summarized in Table 2 . With whole mounts, the numbers of PIL/rat in isoflavone fed rats were significantly decreased compared to the basal diet group. Similarly, in the tissue block sections, the incidence and number of malignant lesions (atypical hyperplasias and adenocarcinomas) in the isoflavone fed group were significantly lower than in the basal diet group (Table 2) . Although there was no difference in tumor incidence between the 2 groups on day 56, the mean tumor weight in the transgenic rats fed isoflavones was approximately one fourth of that in the basal diet group. Only one out of 12 nontransgenic rats fed basal diet developed an adenocarcinoma on day 56, and no statistically significant effect of isoflavones could be detected (Table 3 ). 
DISCUSSION
The present study showed that a simple method with examination of only 2 histologic sections through AIMG is sensitive and more practical for early detection of small neoplastic lesions than examination of whole mount preparations of the contralateral glands. Furthermore, we obtained clear evidence that the same approach is appropriate for assessment of isoflavone inhibition.
Whole mount preparations are frequently used as a convenient method for the examination of small proliferative lesions in entire mammary glands without excising each gland (13, 33) . However, since the whole mount preparation requires considerable time and effort to remove the mammary tissue and an assay model requires a certain number of animals for the purpose of effective statistical analyses, it is not practically suitable for evaluation of effects of carcinogens and modifying compounds. The present comparison of sensitivity and practicability for detection of small early lesions indicated that examination of only 2 histologic sections is sensitive and more practical than employment of whole mount preparations. Although examination of all mammary glands may increase the sensitivity of detection, it is of great advantage that as few as 2 histologic sections can be used without great loss of accuracy (Table 1 ). Our assay system has the distinct advantage of requiring only a short experimental period, which might allow reduction in the number of animals required if many compounds need be evaluated.
Hras128 rats develop palpable adenocarcinomas as early as 20 days after MNU administration at an incidence of about 45%. The latency is in good agreement with the 21 days observed when MNU (50 mg/kg) was administered i.p. to 21-day-old weaning rats (34) ( Table 2 ). We therefore speculate that the mammary gland of the 50-day-old Hras128 rat biologically resembles that of young immature wild-type animals (32, 33) . In fact the number of TEBs in 49-day-old Hras128 rats is greater than that in their wild-type counterparts (Y. Matsuoka, unpublished data). It should be noted that PIL in whole mounts in the current study were located proximal to TEB ( Figures 1B and 1C) , the distance from the tips of TEB perhaps representing the time lag during which TEBs migrate to sites distal to those where the initial carcinogenic events occur.
The data shown in Table 1 provide a number of insights about the sequence of occurrence of morphologically detectable changes during chemically induced mammary carcinogenesis in Hras128 rats. No morphologically detectable lesions were apparent over the first 5 days following carcinogenic insult. At some point between day 5 and 10 after MNU injection, intraductal proliferation occurred in 44% of the animals. The subsequent emergence of both atypical hyperplasias and adenocarcinomas at day 20 is consistent with the hypothesis that foci of intraductal proliferation evolve through atypical hyperplasia to become invasive carcinomas. However, it is also possible that some foci progress directly to adenocarcinomas without an atypical hyperplasia stage, as proposed by other investigators from studies of non-transgenic rats (21, 34) . Furthermore, our results indicate that carcinogenic process in Hras128 rats is fundamentally the same as observed in nontransgenic rats, albeit with an extremely short latent period. Soy isoflavones (eg, genistein) are widely considered to be responsible for the low rate of breast cancer in Asian women and several possible mechanisms have been proposed. These include inhibition of topoisomerase II and protein tyrosine kinase activity, induction of differentiation and apoptosis, and suppression of angiogenesis and invasion (4, 5, 8, 9, 24, 25) . Our findings of significant reduction in numbers of PIL and more remarkably of atypical hyperplasias in AIMG of animals given soy isoflavones at day 20 is thus in line with the literature (Table 2) . Similarly, mammary carcinomas as assayed by total weights for each rat also showed a clear decrease (Table 3) . Although a rapid induction model has been reported in which preneoplastic proliferative lesions and carcinomas could be induced 21 days after MNU injection in immature animals (33, 34) , treatment before weaning is not practical, especially to assess effects of dietary compounds. Furthermore, that our transgenic rats are sexually mature may be advantageous with regard to practical application of the assay models for the search of chemopreventive agents.
Since all of the transgenic rats develop mammary carcinomas within a month after MNU administration, our animals have potential for use in a short-term screening system for preventive agents of mammary carcinogenesis such as isoflavones. Further modification by replacing MNU for DMBA or other carcinogens allowing simple oral administration warrants further practical exploration (11) .
